Searchable abstracts of presentations at key conferences in endocrinology

ea0056p937 | Female Reproduction | ECE2018

Oral glucose tolerance test vs fasting plasma glucose determination for the assessment of glucose metabolism disturbances in women with Polycystic Ovary Syndrome

Ortiz Andres , Fernandez Elena , Alvarez Francisco , Santacruz Elisa , Rosillo Marta , Escobar Hector , Luque Manuel

Background: Polycystic ovary syndrome (PCOS) is a common endocrine condition in women at reproductive age, in whom, glucose metabolism disturbances are commonly observed. In addition, overweight and obesity, especially visceral obesity, are more prevalent in PCOS women, which enhances the resistance to insulin action, and as consequence, the onset of impaired glucose tolerance (IGT) and/or type 2 diabetes mellitus (T2DM). Clinical guidelines recommend oral glucose tolerance te...

ea0056p118 | Endocrine tumours and neoplasia | ECE2018

Comparative study between familial and sporadic pheochromocytoma

Garcia-Sancho Paula , Marengo Agustina P. , Guerrero Fernando , Peiro Inmaculada , Santacruz Elisa , Jose Diez Juan , Iglesias Pedro , Villabona Carles

Introduction: Pheochromocytomas (Pheo) may appear sporadically (SPheo) or as an autosomal dominant inherited disease, named as familial PHEOs (FPheo). The latter are present in younger patients, and usually with multiple tumors, but may occur in patients with apparently simple sporadic tumors with no other syndromic features.Material and methods: Clinical data of all consecutive patients underwent surgery for Pheo over 35 years in two tertiary referral c...

ea0049ep88 | Adrenal medulla | ECE2017

Pheochromocytoma in neurofibromatosis type 1

Marengo Agustina Pia , Garcia-Sancho Paula , Guerrero Fernando , Peiro Inmaculada , Santacruz Elisa , Ortiz Andres , Diez Juan Jose , Iglesias Pedro , Villabona Carles

Background: Individuals with neurofibromatosis type-1 (NF1) carry an increased risk of pheochromocytoma (PHEO). Detection strategy is unknown but most experts recommend screening if hypertension develops.Objective: Report the characteristics of PHEO in patients with NF1 (NF1 group) and compare them with non-NF1-associated PHEO (non-NF1 group).Methods: Retrospective cohort study of patients undergoing PHEO resection in two Spanish t...

ea0049ep94 | Adrenal medulla | ECE2017

Pheochromocytoma: a clinical and pathological study

Santacruz Elisa , Marengo Agustina Pia , Ortiz Andres , Peiro Inma , Pian Hector , Diez Juan Jose , Garcia-Sancho Paula , Villabona Carles , Iglesias Pedro

Objective: To assess clinical features, diagnosis, treatment and outcome in patients with pheochromocytoma surgically treated in the past 3 decades in two tertiary referral hospitals.Methods: A retrospective study on clinical and pathological characteristics, treatment, and outcome in patients with pheochromocytoma followed up in specialized neuroendocrinology units who underwent surgery in the period 1981–2016 was performed.R...

ea0056gp46 | Adrenal medulla and NETs | ECE2018

Comparative study between incidental and symptomatic pheochromocytoma

Santacruz Elisa , Ortiz-Flores Andres , Diez Juan Jose , Pian Hector , Marengo Agustina P , Garcia-Sancho Paula , Peiro Inmaculada , Villabona Carles , Iglesias Pedro

Introduction: The widespread use of abdominal computed tomography and magnetic resonance imaging has led to a rise in the diagnosis of incidental adrenal lesions, some of them are pheochromocytomas (Pheo).Objective: To investigate the differences between incidental (IPheo) and symptomatic Pheo (SPheo).Methods: A multicenter retrospective study on clinical and pathological characteristics, treatment and outcome in patients with Pheo...

ea0056p114 | Endocrine tumours and neoplasia | ECE2018

Are there any clinical predictor for malignancy in malignant pheochromocytoma?

Pia Marengo Agustina , Garcia-Sancho Paula , Guerrero Perez Fernando , Peiro Inmaculada , Santacruz Elisa , Ortiz Flores Andres , Jose Diez Juan , Iglesias Pedro , Villabona Carles

Introduction: Malignant pheochromocytoma (MPheo) is diagnosed by the presence of invasion of adjacent structures or distant metastasis. Predictive factors of malignancy for pheochromocytoma (Pheo) are not well known.Material and methods: We retrospectively analyzed clinical, biochemical, radiological characteristics as predictors for malignancy in patients with Pheo in two Spanish tertiary hospitals during the past 35 years. We also evaluated time of rec...